Use of human immunoglobulin for treatment of severe erythema multiforme in a cat.
A 5-month old female domestic shorthair cat developed lethargy and severe ulcerative skin lesions that covered more than half of its body after routine administration of rabies vaccine, anthelmintic, and ear medication. Clinical and histologic findings were consistent with a severe cutaneous drug reaction or erythema multiforme. The cat's condition continued to deteriorate despite drug withdrawal and supportive care. Administration of human intravenous immunoglobulin was well tolerated by the cat and led to rapid resolution of ulcerative cutaneous lesions, accompanied by substantial improvement in the cat's demeanor within 8 days. Human intravenous immunoglobulin appears to be a novel promising treatment for life-threatening cutaneous drug reactions.
Byrne
Kevin P
KP
Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia 19104-6010, USA.
Giger
Urs
U
D000818:Animals; D002371:Cat Diseases / Q000139:chemically induced / Q000276:immunology / Q000628:therapy*; D002415:Cats; D004892:Erythema Multiforme / Q000139:chemically induced / Q000276:immunology / Q000628:therapy / Q000662:veterinary*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use*; D012867:Skin / Q000473:pathology
D016756:Immunoglobulins, Intravenous